Word: next
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
Nouri praises Khatami for making government more accountable but warns that the President's program will face "serious problems" if reform forces are unfairly excluded from the next parliament. "If the rules of the game are observed," says Nouri, "Khatami will come out with flying colors." With Iran's turbulent transition, however, that remains a very...
...Ayatullah Khomeini, undermining the authority of Iran's ruling clergy and promoting relations with the U.S. If he is convicted, he faces a hefty fine, lashes of the whip or a dozen years in prison. Much more critically, Nouri will then be disqualified from heading the reform ticket in next February's elections, thus ending any chance of his becoming the powerful speaker of Iran's 270-seat parliament, the Majlis-e-Shura. A victory by Nouri is crucial to his chief ally, the embattled reformist President of Iran, Mohammed Khatami, and his efforts to promote moderation, expand freedom...
...lurched repeatedly from giddy euphoria to violent despair and back. But despite the ethnic violence, lynchings and looting in major cities and the carnage in seceding East Timor, this sprawling archipelago of 210 million people has not disintegrated into ungovernability or civil war. Some had predicted the world's next Yugoslavia, but after last week, Indonesia had instead completed its graduation from a military-backed dictatorship to the world's third largest democracy (after India and the U.S.). "Indonesia is born again," said military historian Salim Said. "This is a chance to finally see if civilians can run the country...
Striking with cruel randomness across an increasingly elderly population, Alzheimer's disease afflicts some 4 million Americans, most of them over the age of 65. They may range from a former President to a neighbor next door, but the ailment is always the same: it clutters the brain with tiny bits of protein, slowly robbing victims of their mental power until they are no longer able to do even the simplest chores or recognize their closest friends and kin. So far, medical science has been stymied, unable to treat the disease or slow its fatal progression...
...next step is to turn this laboratory triumph into a medication--one that can stop the enzyme without causing disastrous side effects. That won't be easy, and, as Citron points out, it won't happen overnight. Nor will the Amgen scientists lack for competition. Even as their Science paper appeared, other drugmakers indicated they were hot on the trail of the enzyme as well. And while Alzheimer's researchers offered the usual caveats, they seemed almost unanimously agreed that the identifying of the shadowy enzyme was not only a potential bonanza for drug companies but also the first really...